Skip to main content
Veterinary Medicines

EE LAYERPLUS

Authorised
  • Newcastle disease virus, strain Ulster 2C, Inactivated
  • Haemorrhagic enteritis virus, strain Domermuth, Inactivated

Product identification

Medicine name:
EE LAYERPLUS
EE LAYERPLUS
Active substance:
  • Newcastle disease virus, strain Ulster 2C, Inactivated
  • Haemorrhagic enteritis virus, strain Domermuth, Inactivated
Target species:
  • Turkey (for meat production)
  • Turkey (for reproduction)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Newcastle disease virus, strain Ulster 2C, Inactivated
    8.00
    log 10 50% embryo infective dose
    /
    0.25
    millilitre(s)
  • Haemorrhagic enteritis virus, strain Domermuth, Inactivated
    1.00
    antigen unit(s)
    /
    0.25
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Turkey (for meat production)
      • Meat and offal
        0
        day
    • Turkey (for reproduction)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01CA03
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health Italia S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."